Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
RB Global
RBA
$16B
| $13.9M | ﹤0.01% |
134,975
-30,612
| -18% | -$3.11M |
|
1452
Federated Hermes
FHI
$4.74B
| $13.9M | ﹤0.01% |
266,638
+53,134
| +25% | +$2.7M |
|
1453
PUT
Coca-Cola
KO
$376B
| $13.9M | ﹤0.01% |
198,500
| – | – |
|
1454
PUT
Maplebear
CART
$11.6B
| $13.9M | ﹤0.01% |
308,000
| – | – |
|
1455
D-Wave Quantum Inc. Common Stock
QBTS
$7.78B
| $13.8M | ﹤0.01% |
528,257
+56,430
| +12% | +$1.64M |
|
1456
CALL
Blackstone
BX
$112B
| $13.8M | ﹤0.01% |
89,500
+80,000
| +842% | +$12.2M |
|
1457
PUT
West Pharmaceutical
WST
$24.4B
| $13.8M | ﹤0.01% |
+50,000
| New | +$13.7M |
|
1458
Core Scientific
CORZ
$6.36B
| $13.8M | ﹤0.01% |
944,537
+198,192
| +27% | +$3.46M |
|
1459
Champion Homes
SKY
$5.23B
| $13.7M | ﹤0.01% |
162,688
+32,913
| +25% | +$2.59M |
|
1460
Cabot Corp
CBT
$4.45B
| $13.7M | ﹤0.01% |
207,206
-60,783
| -23% | -$4.05M |
|
1461
Roku
ROKU
$22.9B
| $13.7M | ﹤0.01% |
126,552
+24,735
| +24% | +$2.51M |
|
1462
CALL
Celsius Holdings
CELH
$7.28B
| $13.7M | ﹤0.01% |
300,000
-1,150,000
| -79% | -$57.9M |
|
1463
BJs Wholesale Club
BJ
$11.9B
| $13.7M | ﹤0.01% |
151,993
-6,778
| -4% | -$622K |
|
1464
Exponent
EXPO
$3.24B
| $13.7M | ﹤0.01% |
196,995
+22,020
| +13% | +$1.55M |
|
1465
Tetra Tech
TTEK
$9.33B
| $13.7M | ﹤0.01% |
407,498
+5,638
| +1% | +$191K |
|
1466
Vaxcyte
PCVX
$8.76B
| $13.7M | ﹤0.01% |
296,195
-97,719
| -25% | -$4.37M |
|
1467
CALL
GE Vernova
GEV
$279B
| $13.7M | ﹤0.01% |
20,900
+9,600
| +85% | +$5.85M |
|
1468
American Financial Group
AFG
$12.1B
| $13.7M | ﹤0.01% |
99,904
-21,559
| -18% | -$2.96M |
|
1469
Bruker
BRKR
$8.83B
| $13.6M | ﹤0.01% |
289,431
+114,904
| +66% | +$4.86M |
|
1470
Berkshire Hathaway Class A
BRK.A
$1.09T
| $13.6M | ﹤0.01% |
18
+9
| +100% | +$6.72M |
|
1471
CALL
Mobileye
MBLY
$7.57B
| $13.6M | ﹤0.01% |
1,300,900
+790,900
| +155% | +$9.88M |
|
1472
Rocket Companies
RKT
$42.6B
| $13.6M | ﹤0.01% |
701,506
+600,944
| +598% | +$10.7M |
|
1473
CALL
Peabody Energy
BTU
$2.94B
| $13.6M | ﹤0.01% |
+457,000
| New | +$13.4M |
|
1474
Assured Guaranty
AGO
$3.35B
| $13.5M | ﹤0.01% |
150,520
+132,185
| +721% | +$11.4M |
|
1475
CALL
Ingersoll Rand
IR
$32.7B
| $13.5M | ﹤0.01% |
170,000
| – | – |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.